As the exclusive CDMO partner for this program, Porton Advanced provided comprehensive process development and manufacturing services, including plasmid, lentiviral vectors and final CAR-T cell ...

The drug, based on the rAAV vector, can deliver the optimized human coagulation ... "The traditional treatment of hemophilia B requires frequent intravenous injections, and the factor level fluctuates ...